- 理想的成長型公司, 本業EPS的成長幅度會大於營收的成長幅度
- 營收到某個數字後, 本業EPS呈現不成比例的增加, 有可能是規模經濟的效應
- 如果是有淡旺季的公司, 是否有淡季不淡, 旺季更旺的情況
- 漲很多的股票要留意 EPS 較上季是否有大幅衰退的情況
- 如果EPS衰退,要觀察同業是不是有一樣的狀況
- 要留意增資減資和公司債對股本及EPS的影響
| 加權平均股數 QoQ YoY | EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | 營收 QoQ YoY | 毛利率(%) QoQ YoY | 營業利益率 QoQ YoY | 稅後淨利率 QoQ YoY | 營業利益 QoQ YoY | 稅後淨利 QoQ YoY | 稅前淨利率(%) QoQ YoY | 稅後淨利率(%) QoQ YoY | 兩季平均(YOY)營收成長率(%) | 兩季平均(YOY)EPS成長率(%) | 兩季平均(YOY)本業EPS成長率(%) | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26Q1 (8) | 1539 | -0.26 | 0.2 | -0.07 | -240.0 | 36.36 | -0.16 | -100.0 | -6.67 | -0.07 | 69.57 | 36.36 | 0 | -100.0 | 0 | 50.00 | -31.11 | 0 | -12291600.00 | -1263869.73 | 0 | -5387700.00 | -833889.87 | 0 | -2.46 | -103.31 | -8.37 | -1.08 | -235.0 | 38.64 | -5387700.00 | -833889.87 | 0 | -5387700.00 | -833889.87 | 0 | -53.84 | 180.00 | -30.77 |
| 25Q4 (7) | 1543 | -0.13 | 979.02 | 0.05 | 600.0 | 112.82 | -0.08 | 38.46 | 0.0 | -0.23 | 17.86 | 94.42 | 0.12 | -7.69 | 33.33 | 72.58 | 4.39 | -0.75 | -972.46 | 35.25 | 29.15 | 646.17 | 1221.43 | 207.77 | -1.21 | 39.8 | 6.2 | 0.8 | 1100.0 | 242.86 | 646.17 | 1221.43 | 207.77 | 646.17 | 1221.43 | 207.77 | 0.32 | 346.88 | 4.23 |
| 25Q3 (6) | 1545 | 0.13 | 1011.51 | -0.01 | 93.75 | 98.99 | -0.13 | -30.0 | -30.0 | -0.28 | 0.0 | 92.67 | 0.13 | 8.33 | -43.48 | 69.53 | 3.73 | 1.02 | -1501.89 | -16.39 | -128.08 | -57.62 | 97.17 | 90.26 | -2.01 | -27.22 | -31.37 | -0.08 | 96.79 | 94.2 | -57.62 | 97.17 | 90.26 | -57.62 | 97.17 | 90.26 | 4.17 | 24.15 | 1.66 |
| 25Q2 (5) | 1543 | 0.46 | 1010.07 | -0.16 | -45.45 | 87.4 | -0.10 | 33.33 | 23.08 | -0.28 | -154.55 | 90.11 | 0.12 | 0 | 50.0 | 67.03 | 0 | 0.12 | -1290.39 | 0 | 47.95 | -2037.45 | 0 | 9.48 | -1.58 | 30.4 | 18.97 | -2.49 | -41.48 | -40.68 | -2037.45 | 0 | 9.48 | -2037.45 | 0 | 9.48 | - | - | 0.00 |
| 25Q1 (4) | 1536 | 974.13 | 0.0 | -0.11 | 71.79 | 0.0 | -0.15 | -87.5 | 0.0 | -0.11 | 97.33 | 0.0 | 0 | -100.0 | 0.0 | 0.00 | -100.0 | 0.0 | 0.00 | 100.0 | 0.0 | 0.00 | 100.0 | 0.0 | -2.27 | -75.97 | 0.0 | -1.76 | -214.29 | 0.0 | 0.00 | 100.0 | 0.0 | 0.00 | 100.0 | 0.0 | - | - | 0.00 |
| 24Q4 (3) | 143 | 2.88 | 0.0 | -0.39 | 60.61 | 0.0 | -0.08 | 20.0 | 0.0 | -4.12 | -7.85 | 0.0 | 0.09 | -60.87 | 0.0 | 73.13 | 6.25 | 0.0 | -1372.49 | -108.43 | 0.0 | -599.57 | -1.36 | 0.0 | -1.29 | 15.69 | 0.0 | -0.56 | 59.42 | 0.0 | -599.57 | -1.36 | 0.0 | -599.57 | -1.36 | 0.0 | - | - | 0.00 |
| 24Q3 (2) | 139 | 0.0 | 0.0 | -0.99 | 22.05 | 0.0 | -0.10 | 23.08 | 0.0 | -3.82 | -34.98 | 0.0 | 0.23 | 187.5 | 0.0 | 68.83 | 2.81 | 0.0 | -658.48 | 73.44 | 0.0 | -591.52 | 73.72 | 0.0 | -1.53 | 21.54 | 0.0 | -1.38 | 22.03 | 0.0 | -591.52 | 73.72 | 0.0 | -591.52 | 73.72 | 0.0 | - | - | 0.00 |
| 24Q2 (1) | 139 | 0.0 | 0.0 | -1.27 | 0.0 | 0.0 | -0.13 | 0.0 | 0.0 | -2.83 | 0.0 | 0.0 | 0.08 | 0.0 | 0.0 | 66.95 | 0.0 | 0.0 | -2478.99 | 0.0 | 0.0 | -2250.89 | 0.0 | 0.0 | -1.95 | 0.0 | 0.0 | -1.77 | 0.0 | 0.0 | -2250.89 | 0.0 | 0.0 | -2250.89 | 0.0 | 0.0 | - | - | 0.00 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026/4 | 0.04 | 178200.0 | -70.79 | 0.04 | -70.78 | 0.04 | N/A | 本公司新藥仍在研發階段,目前營收來源為健康食品銷售,僅於出貨予代理商之月份認列營收,因並非每月固定出貨致使營收變動。 | ||
| 2026/3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1500.0 | 本公司新藥仍在研發階段,目前營收來源為健康食品銷售,僅於出貨予代理商之月份認列營收,因並非每月固定出貨致使營收變動。 | ||
| 2026/2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0 | 本公司新藥仍在研發階段,目前營收來源為健康食品銷售,僅於出貨予代理商之月份認列營收,因並非每月固定出貨致使營收變動。 | ||
| 2026/1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.12 | 0.24 | 本公司新藥仍在研發階段,目前營收來源為健康食品銷售,僅於出貨予代理商之月份認列營收,因並非每月固定出貨致使營收變動。 | ||
| 2025/12 | 0.0 | -100.0 | 0.0 | 0.38 | -14.39 | 0.12 | 0.24 | 本公司新藥仍在研發階段,目前營收來源為健康食品銷售,僅於出貨予代理商之月份認列營收,因並非每月固定出貨致使營收變動。 | ||
| 2025/11 | 0.12 | 0.0 | 32.54 | 0.38 | -14.39 | 0.12 | 0.24 | 本公司新藥仍在研發階段,目前營收來源為健康食品銷售,僅於出貨予代理商之月份認列營收,因並非每月固定出貨致使營收變動。 | ||
| 2025/10 | 0.0 | 0.0 | 0.0 | 0.26 | -26.92 | 0.06 | 0.54 | 本公司新藥仍在研發階段,目前營收來源為健康食品銷售,僅於出貨予代理商之月份認列營收,因並非每月固定出貨致使營收變動。 | ||
| 2025/9 | 0.0 | -100.0 | -100.0 | 0.26 | -26.92 | 0.13 | 0.37 | 本月健康食品銷售較去年同期減少 | ||
| 2025/8 | 0.06 | -28.84 | -54.06 | 0.26 | 6.97 | 0.13 | 0.37 | 本月健康食品銷售較去年同期減少。 | ||
| 2025/7 | 0.08 | 0.0 | 0.0 | 0.2 | 69.71 | 0.08 | 0.64 | 本月健康食品銷售較去年同期增加 | ||
| 2025/6 | 0.0 | 0.0 | 0.0 | 0.12 | 3.36 | 0.12 | 0.57 | 本期健康食品銷售較去年同期增加 | ||
| 2025/5 | 0.0 | -100.0 | -100.0 | 0.12 | 3.36 | 0.12 | 0.57 | 本月健康食品銷售較去年同期減少。 | ||
| 2025/4 | 0.12 | 0.0 | 0.0 | 0.12 | 207.91 | 0.12 | 0.57 | 本期健康食品銷售較去年同期增加。 | ||
| 2025/3 | 0.0 | 0.0 | 0.0 | 0.0 | -100.0 | 0.0 | 0 | 本期健康食品銷售較去年同期減少 | ||
| 2025/2 | 0.0 | 0.0 | -100.0 | 0.0 | -100.0 | 0.0 | 0 | 本期健康食品銷售較去年同期減少。 | ||
| 2025/1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.09 | 0.75 | 本月無健康食品收入 | ||
| 2024/12 | 0.0 | -100.0 | -100.0 | 0.44 | 14.13 | 0.09 | 0.32 | 本月健康食品銷售較去年同期減少。 | ||
| 2024/11 | 0.09 | 0.0 | 7768.06 | 0.44 | 52.15 | 0.2 | 0.15 | 本期健康食品銷售較去年同期增加。 | ||
| 2024/10 | 0.0 | -100.0 | -100.0 | 0.35 | 20.58 | 0.0 | N/A | 本月健康食品銷售較去年同期減少。 | ||
| 2024/9 | 0.11 | -8.44 | 0.0 | 0.35 | 45.97 | 0.0 | N/A | 本期健康食品銷售較去年同期增加 | ||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A |
| 加權平均股數 YoY | EPS YoY | 本業EPS YoY | 營收 YoY | 毛利率(%) YoY | 營業利益率 YoY | 稅後淨利率 YoY | 營業利益 YoY | 稅前淨利 YoY | 稅後淨利 YoY | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 (5) | 1530 | 969.93 | -0.23 | 0 | -0.46 | 0 | 0.38 | -13.64 | 69.72 | 0.71 | -1859.31 | 0 | -925.20 | 0 | -7.07 | 0 | -3.52 | 0 | -3.52 | 0 |
| 2024 (4) | 143 | 15.32 | -4.12 | 0 | -0.47 | 0 | 0.44 | 12.82 | 69.23 | -1.88 | -1613.95 | 0 | -1325.18 | 0 | -7.17 | 0 | -5.89 | 0 | -5.89 | 0 |
| 2023 (3) | 124 | 110.17 | -3.94 | 0 | -0.33 | 0 | 0.39 | 200.0 | 70.56 | -5.84 | -1318.88 | 0 | -1254.64 | 0 | -5.13 | 0 | -4.88 | 0 | -4.88 | 0 |
| 2022 (2) | 59 | -10.61 | -4.89 | 0 | -0.21 | 0 | 0.13 | 8.33 | 74.94 | 0.15 | -2493.17 | 0 | -2232.10 | 0 | -3.2 | 0 | -2.86 | 0 | -2.86 | 0 |
| 2021 (1) | 66 | 78.38 | -3.41 | 0 | -0.15 | 0 | 0.12 | 20.0 | 74.83 | 0 | -1869.95 | 0 | -1817.76 | 0 | -2.31 | 0 | -2.24 | 0 | -2.24 | 0 |
免責聲明
本網站所有資料僅供參考,如使用者依本資料交易發生交易損失需自行負責,本網站對資料內容錯誤﹑更新延誤不負任何責任。